Your browser doesn't support javascript.
Management of multiple myeloma during COVID-19 pandemic.
Jethava, Y S; Fonseca, Rafael; Landgren, Ola.
  • Jethava YS; Division of Hematology and Cellular Therapy, University of Iowa Hospitals and Clinics, 200 Hawkins Dr, 5970 JPP, Iowa City, IA 52242, United States.
  • Fonseca R; Interim Executive Director, Mayo Clinic Comprehensive Cancer Center, Director for Innovation and Transformational Relationships, Getz Family Professor of Cancer, Distinguished Mayo Investigator, 5777 East Mayo Boulevard, Phoenix, AZ 85054, United States.
  • Landgren O; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States.
Leuk Res Rep ; 14: 100212, 2020.
Article in English | MEDLINE | ID: covidwho-661476
ABSTRACT
At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019.

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Leuk Res Rep Year: 2020 Document Type: Article Affiliation country: J.lrr.2020.100212

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Leuk Res Rep Year: 2020 Document Type: Article Affiliation country: J.lrr.2020.100212